Company / Return on Equity (ROE)
BioCardia, Inc. Return on Equity (ROE) History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-110.6%
FY2017
5-year range
-110.6% / 74.5%
FY2013-FY2017
Trend
-120.9%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BioCardia, Inc. reports negative total equity of -110.6% in FY2017. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-110.6% in FY2017.
Declined from 74.5% to -110.6% over the past 6 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2017, return on equity (roe) decreased 120.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | -110.6% | -120.9% |
| FY2016 | -50.1% | -167.3% |
| FY2011 | 74.5% | - |
As of FY2017 · SEC Form 10-K · Last checked Jun 21, 2026